News
1don MSN
Cardiff Oncology, Inc. (NASDAQ:CRDF) announced groundbreaking Phase 1b clinical trial results for its PLK1 inhibitor ...
Researchers compare relacorilant plus nab-paclitaxel with nab-paclitaxel monotherapy in patients with platinum-resistant ...
Relacorilant combined with nab-paclitaxel (Abraxane) significantly improved progression-free and overall survival in patients with platinum-resistant ovarian cancer in the phase 3 ROSELLA trial, ...
A new study finds that regular exercise can help colon cancer survivors live longer lives after diagnosis, and in some cases, even longer than people who didn't have cancer. Colon cancer is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results